Nalini Murdter

Nalini Murdter is a Scientific Advisor at Bikanta. Nalini has also served as the President and CEO of MBL International Corporation from January 2016 to October 2019. Nalini was also on the Board of Directors for the National Lymphedema Network from January 2011 to December 2015. Prior to that, they were the Chief Business Officer for NanoString Technologies from January 2010 to December 2013. Nalini started their career at Agilent Technologies in January 2000 as a Global Marketing Manager and Sr. Director, Acquisitions, Alliances and Ventures.

Nalini Murdter's educational career includes a post doc in molecular biology from Caltech, an MBA in marketing and finance from the University of California, Berkeley, Haas School of Business, a Ph.D. in biochemistry and molecular biology from the University of Maryland, and an M.Sc. in chemistry from the Indian Institute of Technology in Kanpur. Nalini also has a certification from Santa Clara University's Leavey School of Business in their Women's Corporate Board Readiness Program.